{"entity":{"type":"insider","cik":"0001440514","url":"/insider/0001440514","json_url":"/insider/0001440514.json","name":"US VENTURE PARTNERS X LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":80,"n_filings":16,"first":"2020-05-27","last":"2022-08-03","span_basis":"filed_date"},"name_variants":[{"name":"US VENTURE PARTNERS X LP","source":"filing","n_filings":16,"first_seen":"2020-05-27","last_seen":"2022-08-03"}],"transactions":[{"id":6208479,"accession":"0001062993-22-017215","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59376.0,"shares_display":"59,376","price_per_share":0.804,"price_display":"0.80","price_state":"stated","total_value":47738.304,"total_display":"47,738.30","total_whole":"47,738","shares_owned_after":3981940.0,"shares_owned_after_display":"3,981,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-03","scope":"insider","n_lines":2},{"id":6208470,"accession":"0001062993-22-017215","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28201.0,"shares_display":"28,201","price_per_share":0.797,"price_display":"0.80","price_state":"stated","total_value":22476.197,"total_display":"22,476.20","total_whole":"22,476","shares_owned_after":4039520.0,"shares_owned_after_display":"4,039,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider","n_lines":2},{"id":6208463,"accession":"0001062993-22-017215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-017215","line_url":"/filing/0001062993-22-017215","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; ROOT JONATHAN D; Presidio Management Group X LLC; USVP X AFFILIATES LP","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26703.0,"shares_display":"26,703","price_per_share":0.786,"price_display":"0.79","price_state":"stated","total_value":20988.558,"total_display":"20,988.56","total_whole":"20,989","shares_owned_after":4066868.0,"shares_owned_after_display":"4,066,868","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider","n_lines":2},{"id":6350310,"accession":"0001062993-22-016924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016924","line_url":"/filing/0001062993-22-016924","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Presidio Management Group X LLC; ROOT JONATHAN D; US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP","owner_display_name":"Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32517.0,"shares_display":"32,517","price_per_share":0.892,"price_display":"0.89","price_state":"stated","total_value":29005.164,"total_display":"29,005.16","total_whole":"29,005","shares_owned_after":4092764.0,"shares_owned_after_display":"4,092,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider","n_lines":2},{"id":6984176,"accession":"0001062993-22-016802","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43665.0,"shares_display":"43,665","price_per_share":0.892,"price_display":"0.89","price_state":"stated","total_value":38949.18,"total_display":"38,949.18","total_whole":"38,949","shares_owned_after":4124297.0,"shares_owned_after_display":"4,124,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-27","scope":"insider","n_lines":2},{"id":6984170,"accession":"0001062993-22-016802","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2775.0,"shares_display":"2,775","price_per_share":0.904,"price_display":"0.90","price_state":"stated","total_value":2508.6,"total_display":"2,508.60","total_whole":"2,509","shares_owned_after":4166641.0,"shares_owned_after_display":"4,166,641","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-26","filed_date":"2022-07-27","scope":"insider","n_lines":2},{"id":6984164,"accession":"0001062993-22-016802","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016802","line_url":"/filing/0001062993-22-016802","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; Presidio Management Group X LLC; ROOT JONATHAN D; USVP X AFFILIATES LP","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2279.0,"shares_display":"2,279","price_per_share":0.931,"price_display":"0.93","price_state":"stated","total_value":2121.749,"total_display":"2,121.75","total_whole":"2,122","shares_owned_after":4169332.0,"shares_owned_after_display":"4,169,332","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-27","scope":"insider","n_lines":2},{"id":6676403,"accession":"0001062993-22-016678","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7614.0,"shares_display":"7,614","price_per_share":0.9100303388494878,"price_display":"0.91","price_state":"stated","total_value":6928.971,"total_display":"6,928.97","total_whole":"6,929","shares_owned_after":4171542.0,"shares_owned_after_display":"4,171,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-22","scope":"insider","n_lines":2},{"id":6676393,"accession":"0001062993-22-016678","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2665.0,"shares_display":"2,665","price_per_share":0.9550303939962477,"price_display":"0.96","price_state":"stated","total_value":2545.156,"total_display":"2,545.16","total_whole":"2,545","shares_owned_after":4178925.0,"shares_owned_after_display":"4,178,925","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-07-22","scope":"insider","n_lines":2},{"id":6676385,"accession":"0001062993-22-016678","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016678","line_url":"/filing/0001062993-22-016678","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Presidio Management Group X LLC; USVP X AFFILIATES LP; ROOT JONATHAN D; Tansey Casey M","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10030.0,"shares_display":"10,030","price_per_share":1.001,"price_display":"1.00","price_state":"stated","total_value":10040.03,"total_display":"10,040.03","total_whole":"10,040","shares_owned_after":4181509.0,"shares_owned_after_display":"4,181,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-22","scope":"insider","n_lines":2},{"id":6365696,"accession":"0001062993-22-016514","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_display_name":"USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2754.0,"shares_display":"2,754","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":2754.0,"total_display":"2,754.00","total_whole":"2,754","shares_owned_after":4191235.0,"shares_owned_after_display":"4,191,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-19","scope":"insider","n_lines":2},{"id":6365694,"accession":"0001062993-22-016514","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_display_name":"USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20987.0,"shares_display":"20,987","price_per_share":1.080030256825654,"price_display":"1.08","price_state":"stated","total_value":22666.595,"total_display":"22,666.60","total_whole":"22,667","shares_owned_after":4193905.0,"shares_owned_after_display":"4,193,905","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-19","scope":"insider","n_lines":2},{"id":6365692,"accession":"0001062993-22-016514","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016514","line_url":"/filing/0001062993-22-016514","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"USVP X AFFILIATES LP; ROOT JONATHAN D; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; Tansey Casey M","owner_display_name":"USVP X AFFILIATES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45900.0,"shares_display":"45,900","price_per_share":1.108,"price_display":"1.11","price_state":"stated","total_value":50857.2,"total_display":"50,857.20","total_whole":"50,857","shares_owned_after":4214257.0,"shares_owned_after_display":"4,214,257","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-19","scope":"insider","n_lines":2},{"id":6208218,"accession":"0001062993-22-013050","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8574.0,"shares_display":"8,574","price_per_share":1.6899689759738745,"price_display":"1.69","price_state":"stated","total_value":14489.794,"total_display":"14,489.79","total_whole":"14,490","shares_owned_after":4258734.0,"shares_owned_after_display":"4,258,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":6208210,"accession":"0001062993-22-013050","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14086.0,"shares_display":"14,086","price_per_share":1.734,"price_display":"1.73","price_state":"stated","total_value":24425.124,"total_display":"24,425.12","total_whole":"24,425","shares_owned_after":4267042.0,"shares_owned_after_display":"4,267,042","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":6208203,"accession":"0001062993-22-013050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-013050","line_url":"/filing/0001062993-22-013050","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; Presidio Management Group X LLC; US VENTURE PARTNERS X LP; USVP X AFFILIATES LP; ROOT JONATHAN D","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11767.0,"shares_display":"11,767","price_per_share":1.7490310189513045,"price_display":"1.75","price_state":"stated","total_value":20580.848,"total_display":"20,580.85","total_whole":"20,581","shares_owned_after":4280691.0,"shares_owned_after_display":"4,280,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":6695414,"accession":"0001062993-22-012659","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12769.0,"shares_display":"12,769","price_per_share":1.746,"price_display":"1.75","price_state":"stated","total_value":22294.674,"total_display":"22,294.67","total_whole":"22,295","shares_owned_after":4292093.0,"shares_owned_after_display":"4,292,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-16","scope":"insider","n_lines":2},{"id":6695410,"accession":"0001062993-22-012659","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22607.0,"shares_display":"22,607","price_per_share":1.839,"price_display":"1.84","price_state":"stated","total_value":41574.273,"total_display":"41,574.27","total_whole":"41,574","shares_owned_after":4304467.0,"shares_owned_after_display":"4,304,467","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-16","scope":"insider","n_lines":2},{"id":6695406,"accession":"0001062993-22-012659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-012659","line_url":"/filing/0001062993-22-012659","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10800.0,"shares_display":"10,800","price_per_share":2.003,"price_display":"2.00","price_state":"stated","total_value":21632.4,"total_display":"21,632.40","total_whole":"21,632","shares_owned_after":4326373.0,"shares_owned_after_display":"4,326,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider","n_lines":2},{"id":6239498,"accession":"0001062993-22-012169","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.345031,"price_display":"2.35","price_state":"stated","total_value":11725.155,"total_display":"11,725.16","total_whole":"11,725","shares_owned_after":4336837.0,"shares_owned_after_display":"4,336,837","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-11","scope":"insider","n_lines":2},{"id":6239488,"accession":"0001062993-22-012169","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39984.0,"shares_display":"39,984","price_per_share":2.413,"price_display":"2.41","price_state":"stated","total_value":96481.392,"total_display":"96,481.39","total_whole":"96,481","shares_owned_after":4341682.0,"shares_owned_after_display":"4,341,682","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-11","scope":"insider","n_lines":2},{"id":6239482,"accession":"0001062993-22-012169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-012169","line_url":"/filing/0001062993-22-012169","is_derivative":false,"issuer_cik":"0001225480","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001225480","owner_cik":null,"owner_name":"Tansey Casey M; ROOT JONATHAN D; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP; Presidio Management Group X LLC","owner_display_name":"Tansey Casey M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":2.536031,"price_display":"2.54","price_state":"stated","total_value":10144.124,"total_display":"10,144.12","total_whole":"10,144","shares_owned_after":4380425.0,"shares_owned_after_display":"4,380,425","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-09","filed_date":"2022-05-11","scope":"insider","n_lines":2},{"id":4766476,"accession":"0001062993-21-012276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-012276","line_url":"/filing/0001062993-21-012276","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"Presidio Management Group X LLC; Tansey Casey M; USVP X AFFILIATES LP; US VENTURE PARTNERS X LP","owner_display_name":"Presidio Management Group X LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8113.0,"shares_display":"8,113","price_per_share":5.68,"price_display":"5.68","price_state":"stated","total_value":46081.84,"total_display":"46,081.84","total_whole":"46,082","shares_owned_after":4384301.0,"shares_owned_after_display":"4,384,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider","n_lines":2},{"id":4986350,"accession":"0001062993-21-011920","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-011920","line_url":"/filing/0001062993-21-011920","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP; Presidio Management Group X LLC","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19245.0,"shares_display":"19,245","price_per_share":6.437,"price_display":"6.44","price_state":"stated","total_value":123880.065,"total_display":"123,880.06","total_whole":"123,880","shares_owned_after":4392162.0,"shares_owned_after_display":"4,392,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-01","scope":"insider","n_lines":2},{"id":4986343,"accession":"0001062993-21-011920","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-011920","line_url":"/filing/0001062993-21-011920","is_derivative":false,"issuer_cik":"0001440514","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001440514","owner_cik":null,"owner_name":"US VENTURE PARTNERS X LP; Tansey Casey M; USVP X AFFILIATES LP; Presidio Management Group X LLC","owner_display_name":"US VENTURE PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27409.0,"shares_display":"27,409","price_per_share":6.5320310117114815,"price_display":"6.53","price_state":"stated","total_value":179036.438,"total_display":"179,036.44","total_whole":"179,036","shares_owned_after":4410810.0,"shares_owned_after_display":"4,410,810","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-01","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2021-11-30|4986340","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001828522","name":"eFFECTOR Therapeutics, Inc.","url":"/issuer/0001828522","role":"Ten percent owner","n_filings":14,"first_seen":"2021-11-12","last_seen":"2022-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001531048","name":"Inari Medical, Inc.","url":"/issuer/0001531048","role":"Ten percent owner","n_filings":2,"first_seen":"2020-05-27","last_seen":"2020-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001440514","retrieved_at":"2026-08-22T07:43:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}